The Next Generation of Cell & Gene Therapies

Impossible d'ajouter des articles

Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.

Veuillez réessayer plus tard

Échec de l’élimination de la liste d'envies.

Veuillez réessayer plus tard

Impossible de suivre le podcast

Impossible de ne plus suivre le podcast

The Next Generation of Cell & Gene Therapies

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

Our BioTalent Social community came together for an informative discussion on ‘The Next Generation of Cell & Gene Therapies,’ hosted by our very own James Hume. The discussion touched on a multitude of topical themes and insights, including:

The role of tech-transfer offices in turning early-stage interventions into products
Current challenges and opportunities for CGT start-ups in Europe
The complexities of clinical trials, and how we can make this smoother
PHDs: the importance of scientific and entrepreneurial learning
Viral vs. non-viral vectors
Mindset in CGT: the importance of resilience, perseverance and ambiguity tolerance

Thank you to our wonderful panel members Stephen Sullivan, Kerstin Papenfuss and John Counsell for their sharp and focussed insights.

Aucun commentaire pour le moment